Učitavanje...
Tau Immunotherapy and Imaging
Disappointing findings from recent Phase III trials on amyloid-β (Aβ) immunotherapy for Alzheimer’s disease (AD) have shifted the focus of such treatments to the tau protein. As tau pathology correlates better with the degree of dementia than Aβ plaque burden, it is a more attractive target once cog...
Spremljeno u:
| Glavni autor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2013
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3946316/ https://ncbi.nlm.nih.gov/pubmed/24029727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000354491 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|